WAM
DNA icon

Wolverine Asset Management’s Ginkgo Bioworks DNA Stock Holding History

Wolverine Asset Management’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-35
Closed -$4K – 2163
2022
Q3 		$4K Hold
35
– – ﹤0.01% 2175
2022
Q2 		$3K Buy
35
+7
+25% +$854 ﹤0.01% 2179
2022
Q1 		$4K Sell
28
-48
-63% -$9.34K ﹤0.01% 2028
2021
Q4 		$25K Buy
76
+37
+95% +$17.6K ﹤0.01% 1663
2021
Q3 		$18K Buy
+39
New +$19K ﹤0.01% 1658

Other funds holding DNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
GA
General Atlantic New York $2.91B AUM 24.21% 1-Year Est. Return

Wolverine Asset Management's DNA Position: Q4 2022 in Review

Wolverine Asset Management sold out of Ginkgo Bioworks (DNA) in Q4 2022, closing a stake of 35 shares — an estimated $4K sold.

Wolverine Asset Management first reported a position in DNA in Q3 2021 and held it in 5 quarters. The position peaked at $25K in Q4 2021. 320 funds tracked by Wall St. Rank hold DNA as of Q4 2022.

  • Wolverine Asset Management reported no remaining Ginkgo Bioworks position as of Q4 2022 after selling out during the quarter.
  • Wolverine Asset Management sold 35 Ginkgo Bioworks shares in Q4 2022, an estimated $4K.
  • Wolverine Asset Management first reported a position in Ginkgo Bioworks in Q3 2021 and held it in 5 quarters.
  • Wolverine Asset Management's Ginkgo Bioworks position peaked at $25K in Q4 2021.
  • 320 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q4 2022.

Based on Wolverine Asset Management's 13F filing for Q4 2022, filed 1 Feb 2023.